loadpatents
name:-0.030919075012207
name:-0.015660047531128
name:-0.0074710845947266
Leveillard; Thierry Patent Filings

Leveillard; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leveillard; Thierry.The latest application filed is for "method for treating retinal degeneration disease by administering nucleolin polynucleotide or polypeptide".

Company Profile
7.19.27
  • Leveillard; Thierry - Maisons-Alfort FR
  • Leveillard; Thierry - Paris FR
  • LEVEILLARD; THIERRY - MAISON-ALFORT FR
  • Leveillard; Thierry - Charenton N/A FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Neuronal viability factor and use thereof in Alzheimer's disease
Grant 11,428,698 - Leveillard , et al. August 30, 2
2022-08-30
Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
Grant 11,313,852 - Perrocheau , et al. April 26, 2
2022-04-26
Method For Treating Retinal Degeneration Disease By Administering Nucleolin Polynucleotide Or Polypeptide
App 20210338773 - LEVEILLARD; Thierry ;   et al.
2021-11-04
Methods And Compositions For Treatment Of Retinal Degenerative Diseases
App 20210308169 - SAHEL; Jose-Alain ;   et al.
2021-10-07
Methods Of Expressing A Polynucleotide Of Interest In The Cone Photoreceptors Of A Subject Comprising The Subretinal Delivery Of A Therapeutically Effective Amount Of A Recombinant Aav9-derived Vector
App 20210268125 - DALKARA; DENIZ ;   et al.
2021-09-02
Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries
App 20210069346 - Leveillard; Thierry ;   et al.
2021-03-11
Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries
Grant 10,857,239 - Leveillard , et al. December 8, 2
2020-12-08
Constructs Comprising Neuronal Viability Factors And Uses Thereof
App 20200318138 - LEVEILLARD; Thierry ;   et al.
2020-10-08
Neuronal Viability Factor And Use Thereof
App 20200174023 - Leveillard; Thierry ;   et al.
2020-06-04
Synergistic combination of neuronal viability factors and uses thereof
Grant 10,668,129 - Leveillard , et al.
2020-06-02
Pharmaceutical Compositions For The Treatment Of Retinal Degenerative Diseases
App 20190328846 - LEVEILLARD; Thierry ;   et al.
2019-10-31
Neuronal Viability Factor And Use Thereof
App 20190064189 - Leveillard; Thierry ;   et al.
2019-02-28
Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries
App 20180179259 - Leveillard; Thierry ;   et al.
2018-06-28
Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)
Grant 10,004,780 - Leveillard , et al. June 26, 2
2018-06-26
Synergistic Combination Of Neuronal Viability Factors And Uses Thereof
App 20180153962 - LEVEILLARD; Thierry ;   et al.
2018-06-07
Transgenic Rpe Cells Overexpressing Otx2 For The Treatment Of Retinal Degeneration
App 20170348434 - LEVEILLARD; THIERRY ;   et al.
2017-12-07
Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
App 20170176417 - Perrocheau; Ludivine ;   et al.
2017-06-22
Methods for treating cone dystrophy with neuronal viability factor, RDCVF2
Grant 9,575,075 - Leveillard , et al. February 21, 2
2017-02-21
Neuronal Viability Factor And Use Thereof
App 20170014478 - Leveillard; Thierry ;   et al.
2017-01-19
Methods And Compositions For Treatment Of Retinal Degenerative Diseases
App 20160213701 - SAHEL; Jose-Alain ;   et al.
2016-07-28
Methods And Pharmaceutical Compositions For The Treatment Of Age-related Macular Degeneration (amd)
App 20150265676 - Leveillard; Thierry ;   et al.
2015-09-24
Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2
Grant 8,957,043 - Leveillard , et al. February 17, 2
2015-02-17
Methods And Compositions For Treatment Of Retinal Degenerative Diseases
App 20150038557 - Sahel; Jose-Alain ;   et al.
2015-02-05
Neuronal viability factor and use thereof
Grant 8,779,093 - Leveillard , et al. July 15, 2
2014-07-15
Disease-associated Protein
App 20130287738 - LEVEILLARD; Thierry ;   et al.
2013-10-31
Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2
Grant 8,518,695 - Leveillard , et al. August 27, 2
2013-08-27
Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells
Grant 8,394,756 - Leveillard , et al. March 12, 2
2013-03-12
Neuronal Viability Factor and Use Thereof
App 20120245093 - Leveillard; Thierry ;   et al.
2012-09-27
Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
App 20120156221 - Perrocheau; Ludivine ;   et al.
2012-06-21
Trophic factor for the treatment of retinal degenerative diseases
Grant 8,193,153 - Leveillard , et al. June 5, 2
2012-06-05
Disease-associated Protein
App 20120108657 - LEVEILLARD; Thierry ;   et al.
2012-05-03
Disease-associated Protein
App 20120108523 - LEVEILLARD; Thierry ;   et al.
2012-05-03
Retinal dystrophy-associated protein and uses thereof
Grant 8,114,849 - Leveillard , et al. February 14, 2
2012-02-14
Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same
Grant 8,071,745 - Leveillard , et al. December 6, 2
2011-12-06
Trophic Factor for the Treatment of Retinal Degenerative Diseases
App 20100267646 - Leveillard; Thierry ;   et al.
2010-10-21
Neuronal Viability Factor And Use Thereof
App 20100247496 - Leveillard; Thierry ;   et al.
2010-09-30
Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF
Grant 7,795,387 - Leveillard , et al. September 14, 2
2010-09-14
Disease-Associated Protein
App 20090062188 - Leveillard; Thierry ;   et al.
2009-03-05
Disease-Associated Protein
App 20080004231 - Leveillard; Thierry ;   et al.
2008-01-03
Disease- associated protein
App 20040204350 - Leveillard, Thierry ;   et al.
2004-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed